Back

Prognostic value of quantitative anatomical and functional measures of coronary artery disease in diabetic and non-diabetic patients

30 August 2024 (12:00 - 12:40)
Organised by: Logo
Congress Presentation Part of: Positron emission tomography innovations in diagnosis and prognosis Hybrid and Fusion Imaging ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Matias Maenpaa

University of Turku, Turku (Finland)

6 More presentations in this session

Presentation thumbnail
Usefulness of visual classification for cardiac pathophysiology using count-washout rate map in iodine-123-beta-methyl-P-iodophenyl-pentadecanoic acid scintigraphy
Doctor R. Ono (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Heparin does not improve myocardial glucose metabolism suppression in patients with low betahydroxybutyrate level
Doctor S. Hartikainen (Kuopio, FI)
Abstract Slides Video
Presentation thumbnail
Assessment of impact of left ventricular flow state on myocardial blood flow using positron emission tomography and echocardiography
Doctor M. Pu (New York, US) Doctor B. Chen (Bronx, US)
Abstract Slides Video
Presentation thumbnail
Predictive value of cardiac 18F-fluorodeoxyglucose positron emission tomography for fatal ventricular arrhythmic events in patients with cardiac sarcoidosis
Doctor K. Takeuchi (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
18F-FDG PET/CT in the diagnosis of infective endocarditis
Miss L. Salminen (Turku, FI)
Abstract Slides Video

Access the full session

Session thumbnail
Positron emission tomography innovations in diagnosis and prognosis

The Event

Event poster

ESC Congress 2024

30 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Endotypes of coronary microvascular dysfunction in patients with and without Diabetes Mellitus
thumbnail
Congress Presentation
Impact of DM on clinical outcomes in patients with CAD diagnosed by CCTA
thumbnail
Congress Session
Personalised management of patients with diabetes and coronary artery disease: unresolved issues

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources